Specificity Assessment of CRISPR Genome Editing of Oncogenic EGFR Point Mutation with Single-Base Differences
Taegeun Bae1, Hanseop Kim2, Jeong Hee Kim3
1Department of Medicine, Graduate School, Kyung Hee University, Seoul 02447, Korea.
Abstract:
In CRISPR genome editing, CRISPR proteins form ribonucleoprotein complexes with guide RNAs to bind and cleave the target DNAs with complete sequence complementarity. CRISPR genome editing has a high potential for use in precision gene therapy for various diseases, including cancer and genetic disorders, which are caused by DNA mutations within the genome. However, several studies have shown that targeting the DNA via sequence complementarity is imperfect and subject to unintended genome editing of other genomic loci with similar sequences. These off-target problems pose critical safety issues in the therapeutic applications of CRISPR technology, with particular concerns in terms of the genome editing of pathogenic point mutations, where non-mutant alleles can become an off-target with only a one-base difference. In this study, we sought to assess a novel CRISPR genome editing technique that has been proposed to achieve a high specificity by positioning the mismatches within the protospacer adjacent motif (PAM) sequence. To this end, we compared the genome editing specificities of the PAM-based and conventional methods on an oncogenic single-base mutation in the endothelial growth factor receptor (EGFR). The results indicated that the PAM-based method provided a significantly increased genome editing specificity for pathogenic mutant alleles with single-base precision.
Insights
A novel CRISPR genome editing method enhances specificity by targeting the protospacer adjacent motif (PAM) sequence. This PAM-based approach improves precision for gene therapy, particularly for single-base mutations like those in EGFR.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- CRISPR genome editing uses guide RNAs and CRISPR proteins for targeted DNA cleavage.
- CRISPR technology holds promise for gene therapy but faces challenges with off-target mutations due to sequence complementarity.
- Off-target effects are a significant safety concern, especially for precise correction of point mutations.
Purpose of the Study:
- To evaluate a novel CRISPR genome editing technique designed for enhanced specificity.
- To assess the efficacy of a PAM-based mismatch positioning strategy compared to conventional methods.
- To investigate the potential of this technique for precise therapeutic gene editing.
Main Methods:
- Comparison of PAM-based and conventional CRISPR genome editing specificities.
- Targeting an oncogenic single-base mutation in the endothelial growth factor receptor (EGFR) gene.
- Assessment of genome editing precision at the single-base level.
Main Results:
- The PAM-based CRISPR method demonstrated significantly increased genome editing specificity.
- This novel technique precisely targeted pathogenic mutant alleles with single-base accuracy.
- Reduced off-target edits were observed compared to conventional CRISPR methods.
Conclusions:
- The PAM-based CRISPR genome editing technique offers a significant improvement in specificity.
- This method shows potential for safer and more precise gene therapy applications.
- Targeting mismatches within the PAM sequence is a viable strategy for enhancing CRISPR editing accuracy.
More Related Videos
Related Concept Videos
Homologous Recombination
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
CRISPR/Cas9 Genome Editing


